HEALTH● ELEVATEDJul 30 · Jul 30, 2026, 10:00 AM
First-of-kind Guillain-Barré drug switches off part of immune system
New Scientist
A treatment that turns off the bit of the immune system that goes haywire in Guillain-Barré syndrome may be the first targeted therapy approved for the autoimmune condition
GlobeAlert aggregates and classifies open sources; the story above belongs to its publisher. Summaries are machine-generated from the source text.
More in Health
HEALTH44m agoSummit Therapeutics reports survival benefit for cancer drug in trialSeeking Alpha TechHEALTH55m agoUganda orders 21-day Ebola quarantine for citizens returning from DR CongoAl Jazeera [en]HEALTH1h agoBeyond Cholesterol : The Hidden Changes That Shape Heart Healththeepochtimes.com · United StatesHEALTH1h agoEbola: NCDC urges hospitals to act before laboratory confirmationPremium Times